Readers need to be informed about potential pitfalls of [68Ga]Ga-PSMA-11 PET interpretation.
Here we report [68Ga]Ga-PSMA-11 PET findings discordant with the histopathology/composite reference standard in a recently published prospective trial on 635 patients with biochemically recurrent prostate cancer.